Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.

Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies.

Partin AW, Van Neste L, Klein EA, Marks LS, Gee JR, Troyer DA, Rieger-Christ K, Jones JS, Magi-Galluzzi C, Mangold LA, Trock BJ, Lance RS, Bigley JW, Van Criekinge W, Epstein JI.

J Urol. 2014 Apr 16. pii: S0022-5347(14)03341-2. doi: 10.1016/j.juro.2014.04.013. [Epub ahead of print]

PMID:
24747657
[PubMed - as supplied by publisher]
2.

Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.

Nyalwidhe JO, Betesh LR, Powers TW, Jones EE, White KY, Burch TC, Brooks J, Watson MT, Lance RS, Troyer DA, Semmes OJ, Mehta A, Drake RR.

Proteomics Clin Appl. 2013 Jun 17. doi: 10.1002/prca.201200134. [Epub ahead of print]

PMID:
23775902
[PubMed - as supplied by publisher]
3.

In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.

Principe S, Jones EE, Kim Y, Sinha A, Nyalwidhe JO, Brooks J, Semmes OJ, Troyer DA, Lance RS, Kislinger T, Drake RR.

Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.

PMID:
23533145
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.

Lin DW, Newcomb LF, Brown EC, Brooks JD, Carroll PR, Feng Z, Gleave ME, Lance RS, Sanda MG, Thompson IM, Wei JT, Nelson PS; Canary Prostate Active Surveillance Study Investigators.

Clin Cancer Res. 2013 May 1;19(9):2442-50. doi: 10.1158/1078-0432.CCR-12-3283. Epub 2013 Mar 20.

PMID:
23515404
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer.

Lambert JW, Ingham M, Gibbs BB, Given RW, Lance RS, Riggs SB.

Urology. 2013 Mar;81(3):587-92. doi: 10.1016/j.urology.2012.10.055. Epub 2013 Jan 24.

PMID:
23352372
[PubMed - indexed for MEDLINE]
6.

NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy.

Moul JW, Lilja H, Semmes OJ, Lance RS, Vessella RL, Fleisher M, Mazzola C, Sarno MJ, Stevens B, Klem RE, McDermed JE, Triebell MT, Adams TH.

Urology. 2012 Dec;80(6):1319-25. doi: 10.1016/j.urology.2012.06.080. Epub 2012 Oct 26.

PMID:
23107099
[PubMed - indexed for MEDLINE]
7.

Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer.

Kim Y, Ignatchenko V, Yao CQ, Kalatskaya I, Nyalwidhe JO, Lance RS, Gramolini AO, Troyer DA, Stein LD, Boutros PC, Medin JA, Semmes OJ, Drake RR, Kislinger T.

Mol Cell Proteomics. 2012 Dec;11(12):1870-84. doi: 10.1074/mcp.M112.017889. Epub 2012 Sep 17.

PMID:
22986220
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine.

Principe S, Kim Y, Fontana S, Ignatchenko V, Nyalwidhe JO, Lance RS, Troyer DA, Alessandro R, Semmes OJ, Kislinger T, Drake RR, Medin JA.

J Proteome Res. 2012 Apr 6;11(4):2386-96. doi: 10.1021/pr2011236. Epub 2012 Feb 29.

PMID:
22339264
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Molecular preservation by extraction and fixation, mPREF: a method for small molecule biomarker analysis and histology on exactly the same tissue.

Shuster JR, Lance RS, Troyer DA.

BMC Clin Pathol. 2011 Dec 21;11:14. doi: 10.1186/1472-6890-11-14.

PMID:
22188997
[PubMed]
Free PMC Article
10.

Molecular pathology of prostate cancer.

Cazares LH, Drake RR, Esquela-Kirscher A, Lance RS, Semmes OJ, Troyer DA.

Cancer Biomark. 2010;9(1-6):441-59. doi: 10.3233/CBM-2011-0181. Review.

PMID:
22112489
[PubMed - indexed for MEDLINE]
11.

Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer.

Lance RS, Drake RR, Troyer DA.

Expert Rev Anticancer Ther. 2011 Sep;11(9):1341-3. doi: 10.1586/era.11.134.

PMID:
21929308
[PubMed]
12.

In-depth proteomic analyses of direct expressed prostatic secretions.

Drake RR, Elschenbroich S, Lopez-Perez O, Kim Y, Ignatchenko V, Ignatchenko A, Nyalwidhe JO, Basu G, Wilkins CE, Gjurich B, Lance RS, Semmes OJ, Medin JA, Kislinger T.

J Proteome Res. 2010 May 7;9(5):2109-16. doi: 10.1021/pr1001498.

PMID:
20334419
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer.

Malcolm JB, Fabrizio MD, Barone BB, Given RW, Lance RS, Lynch DF, Davis JW, Shaves ME, Schellhammer PF.

J Urol. 2010 May;183(5):1822-8. doi: 10.1016/j.juro.2009.12.102. Epub 2010 Mar 29.

PMID:
20303100
[PubMed - indexed for MEDLINE]
14.

Proteomic expression profiling and identification of serum proteins using immobilized trypsin beads with MALDI-TOF/TOF.

Karbassi ID, Nyalwidhe JO, Wilkins CE, Cazares LH, Lance RS, Semmes OJ, Drake RR.

J Proteome Res. 2009 Sep;8(9):4182-92. doi: 10.1021/pr800836c.

PMID:
19603828
[PubMed - indexed for MEDLINE]
15.

Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease.

Drake RR, White KY, Fuller TW, Igwe E, Clements MA, Nyalwidhe JO, Given RW, Lance RS, Semmes OJ.

J Proteomics. 2009 Aug 20;72(6):907-17. doi: 10.1016/j.jprot.2009.01.007. Epub 2009 Jan 20. Review.

PMID:
19457353
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Single center experience with percutaneous and laparoscopic cryoablation of small renal masses.

Malcolm JB, Berry TT, Williams MB, Logan JE, Given RW, Lance RS, Barone B, Shaves S, Vingan H, Fabrizio MD.

J Endourol. 2009 Jun;23(6):907-11. doi: 10.1089/end.2008.0608.

PMID:
19456244
[PubMed - indexed for MEDLINE]
17.

Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids.

White KY, Rodemich L, Nyalwidhe JO, Comunale MA, Clements MA, Lance RS, Schellhammer PF, Mehta AS, Semmes OJ, Drake RR.

J Proteome Res. 2009 Feb;8(2):620-30. doi: 10.1021/pr8007545.

PMID:
19128049
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Hounsfield unit density accurately predicts ESWL success.

Magnuson WJ, Tomera KM, Lance RS.

Alaska Med. 2005 Jul-Sep;47(2):6-9.

PMID:
16459477
[PubMed - indexed for MEDLINE]
19.

Recent developments in the treatment of bladder cancer.

Lance RS, Grossman HB.

Adv Exp Med Biol. 2003;539(Pt A):3-14. Review. No abstract available.

PMID:
15088892
[PubMed - indexed for MEDLINE]
20.

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.

Amling CL, Riffenburgh RH, Sun L, Moul JW, Lance RS, Kusuda L, Sexton WJ, Soderdahl DW, Donahue TF, Foley JP, Chung AK, McLeod DG.

J Clin Oncol. 2004 Feb 1;22(3):439-45. Epub 2003 Dec 22.

PMID:
14691120
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk